1.Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359, 61–73.
2.Symonds ME, Sebert SP, Hyatt MA, Budge H. Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol. 2009; 5, 604–610.
3.Jansson N, Pettersson J, Haafiz A, et al. Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol. 2006; 576, 935–946.
4.Malandro MS, Beveridge MJ, Kihlberg MS, Novak DA. Effect of low-protein diet-induced intrauterine growth retardation on rat placental amino acid transport. Am J Physiol. 1996; 271, C295–C303.
5.Constancia M, Hemberger M, Hughes J, et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature. 2002; 417, 945–948.
6.Zhu MJ, Du M, Hess BW, Nathanielsz PW, Ford SP. Periconceptional nutrient restriction in the ewe alters MAPK/ERK1/2 and PI3K/Akt growth signaling pathways and vascularity in the placentome. Placenta. 2007; 28, 1192–1199.
7.Zhu MJ, Ma Y, Long NM, Du M, Ford SP. Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. Am J Physiol Regul Integr Comp Physiol. 2010; 299, R1224–R1231.
8.Rosario FJ, Jansson N, Kanai Y, et al. Maternal protein restriction in the rat inhibits placental insulin, mTOR, and STAT3 signaling and down-regulates placental amino acid transporters. Endocrinology. 2011; 152, 1119–1129.
9.Belkacemi L, Nelson DM, Desai M, Ross MG. Maternal undernutrition influences placental-fetal development. Biol Reprod. 2010; 83, 325–331.
10.Kaufmann P, Burton GJ. Anatomy and genesis of the placenta. In The Physiology of Reproduction (eds. Knobil E, Neill JD) 1994; pp. 441–483. Raven Press: New York.
11.Kusinski LC, Jones CJ, Baker PN, Sibley CP, Glazier JD. Isolation of plasma membrane vesicles from mouse placenta at term and measurement of system A and system beta amino acid transporter activity. Placenta. 2010; 31, 53–59.
12.Burton GJ, Kaufmann P, Huppertz B. Anatomy and genesis of the placenta. In Knobil and Neill's Physiology of Reproduction (ed. Neill JD), 2006; pp. 189–241. Elsevier: Amsterdam.
13.Wooding FP, Flint APF. Placentation. In Marshall's Physiology of Reproduction (ed. Lamming GE) 1994; pp. 233–460. Chapman & Hall: London.
14.Carter AM. Evolution of factors affecting placental oxygen transfer. Placenta. 2009; 30(Suppl. A), S19–S25.
15.Jansson T, Powell TL. Placental function in maternofetal exchange. In Fetal Medicine: Basic Science and Clinical Practice (eds. Rodeck CH, Whittle MJ), 2009; pp. 97–109. Churchill Livingstone Elsevier: London.
16.Sibley CP, Boyd RDH. Mechanisms of transfer across the human placenta. In Fetal and Neonatal Physiology (eds. Polin RA, Fox WW), 1998; pp. 77–89. WB Saunders Co.: Philadelphia.
17.Sibley CP, Boyd RDH. Control of transfer across the mature placenta. In Oxford Reviews of Reproductive Biology (ed. Clarke JR), 1988; pp. 382–423. Oxford University Press: Oxford.
18.Atkinson DE, Boyd RDH, Sibley CP. Placental transfer. In Knobil and Neill's Physiology of Reproduction (ed. Neill JD) 2006; pp. 2787–2846. Elsevier: Amsterdam.
19.Jansson T, Powell TL. Human placental transport in altered fetal growth: Does the placenta function as a nutrient sensor? – A review. Placenta. 2006; 27(Suppl.), 91–97.
20.Sibley CP, Brownbill P, Dilworth M, Glazier JD. Review: adaptation in placental nutrient supply to meet fetal growth demand: implications for programming. Placenta. 2010; 31(Suppl.), S70–S74.
21.Constancia M, Angiolini E, Sandovici I, et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc Natl Acad Sci U S A. 2005; 102, 19219–19224.
22.Angiolini E, Coan PM, Sandovici I, et al. Developmental adaptations to increased fetal nutrient demand in mouse genetic models of Igf2-mediated overgrowth. FASEB J. 2011; 25, 1737–1745.
23.Lumey LH. Compensatory placental growth after restricted maternal nutrition in early pregnancy. Placenta. 1998; 19, 105–111.
24.Sibley CP, Turner MA, Cetin I, et al. Placental phenotypes of intrauterine growth. Pediatr Res. 2005; 58, 827–832.
25.Sibley C, D′Souza S, Glazier J, Greenwood S. Mechanisms of solute transfer across the human placenta: effects of intrauterine growth restriction. Fetal Matern Med Rev. 1998; 10, 197–206.
26.Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta. 2009; 30(Suppl. A), S77–S82.
27.Dicke JM, Verges DK. Neutral amino acid uptake by microvillous and basal plasma membrane vesicles from appropriate- and small-for- gestational age human pregnancies. J Matern Fetal Med. 1994; 3, 246–250.
28.Jansson T, Ylvén K, Wennergren M, Powell TL. Glucose transport and system A activity in syncytiotrophoblast microvillous and basal membranes in intrauterine growth restriction. Placenta. 2002; 23, 386–391.
29.Glazier JD, Cetin I, Perugino G, et al. Association between the activity of the system a amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res. 1997; 42, 514–519.
30.Mahendran D, Donnai P, Glazier JD, et al. Amino acid (System A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res. 1993; 34, 661–665.
31.Jansson T, Scholtbach V, Powell TL. Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res. 1998; 44, 532–537.
32.Norberg S, Powell TL, Jansson T. Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatr Res. 1998; 44, 233–238.
33.Roos S, Powell TL, Jansson T. Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 2004; 287, R886–R893.
34.Ayuk PTY, Theophanous D, D'Souza SW, Sibley CP, Glazier JD. l-Arginine transport by the microvillous plasma membrane of the syncytiotrophoblast from human placenta in relation to nitric oxide production: effects of gestation, preeclampsia, and intrauterine growth restriction. J Clin Endocrinol Metab. 2002; 87, 747–751.
35.Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab. 1993; 77, 1554–1562.
36.Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in human placenta in pregnancies complicated by IUGR and diabetes. J Clin Endocrinol Metab. 2004; 89, 4607–4614.
37.Strid H, Bucht E, Jansson T, Wennergren M, Powell T. ATP-dependent Ca2+ transport across basal membrane of human syncytiotrophoblast in pregnancies complicated by diabetes or intrauterine growth restriction. Placenta. 2003; 24, 445–452.
38.Johansson M, Jansson T, Glazier JD, Powell TL. Activity and expression of the Na+/H+ exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies. J Clin Endocrinol Metab. 2002; 87, 5686–5694.
39.Settle P, Sibley CP, Doughty IM, et al. Placental lactate transporter activity and expression in intrauterine growth restriction. J Soc Gynecol Investig. 2006; 13, 357–363.
40.Johansson M, Karlsson L, Wennergren M, Jansson T, Powell TL. Activity and protein expression of Na+K+ ATPase are reduced in microvillous syncytiotrophoblast plasma membranes isolated from pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab. 2003; 88, 2831–2837.
41.Economides DL, Nicolaides KH. Blood glucose and oxygen tension in small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989; 160, 120–126.
42.Zamudio S, Torricos T, Fik E, et al. Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth. PLoS One. 2010; 5, e8551.
43.Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch. 2004; 447, 784–795.
44.Shibata E, Hubel CA, Powers RW, et al. Placental System A amino acid transport is reduced in pregnancies complicated with small for gestational age (SGA) infants but not in preecalmpsia with SGA infants. Placenta. 2008; 29, 879–882.
45.Jansson N, Greenwood S, Johansson BR, Powell TL, Jansson T. Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab. 2003; 88, 1205–1211.
46.von Versen-Hoynck F, Rajakumar A, Parrott MS, Powers RW. Leptin affects system A amino acid transport activity in the human placenta: evidence for STAT3 dependent mechanisms. Placenta. 2009; 30, 361–367.
47.Tsitsiou E, Sibley CP, D'Souza SW, et al. Homocysteine is transported by the microvillous plasma membrane of human placenta. J Inherit Metab Dis. 2011; 34, 57–65.
48.Marconi AM, Paolini CL, Stramare L, et al. Steady state maternal–fetal leucine enrichments in normal and intrauterine growth-restricted pregnancies. Pediatr Res. 1999; 46, 114–119.
49.Paolini CL, Marconi AM, Ronzoni S, et al. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab. 2001; 86, 5427–5432.
50.Cetin I, Corbetta C, Sereni LP, et al. Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. Am J Obstet Gynecol. 1990; 162, 253–261.
51.Cetin I, Marconi AM, Bozzetti P, et al. Umbilical amino acid concentrations in appropriate and small for gestational age infants: a biochemical difference present in utero. Am J Obstet Gynecol. 1988; 158, 120–126.
52.Economides DL, Nicolaides KH, Gahl WA, Bernadini I, Evans MI. Plasma amino acids in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989; 161, 1219–1227.
53.Cetin I, Giovannini N, Alvino G, et al. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal–maternal relationships. Pediatr Res. 2002; 52, 750–755.
54.Heasman L, Clarke L, Firth K, Stephenson T, Symonds ME. Influence of restricted maternal nutrition in early to mid gestation on placental and fetal development at term in sheep. Pediatr Res. 1998; 44, 546–551.
55.Langley-Evans S, Gardner D, Jackson A. Association of disproportionate growth of fetal rats in late gestation with raised systolic blood pressure in later life. J Reprod Fertil. 1996; 106, 307–312.
56.Schlabritz-Loutsevitch N, Ballesteros B, Dudley C, et al. Moderate maternal nutrient restriction, but not glucocorticoid administration, leads to placental morphological changes in the baboon (Papio sp). Placenta. 2007; 28, 783–793.
57.Dwyer CM, Madgwick AJ, Crook AR, Stickland NC. The effect of maternal undernutrition on the growth and development of the guinea pig placenta. J Dev Physiol. 1992; 18, 295–302.
58.Belkacemi L, Chen CH, Ross MG, Desai M. Increased placental apoptosis in maternal food restricted gestations: role of the Fas pathway. Placenta. 2009; 30, 739–751.
59.Kavitha JV, Nathanielsz PW, McDonald TJ, et al. Down regulation of placental amino acid and glucose transporters in response to maternal nutrient restriction in the baboon. Reprod Sci. 2012; 19(Suppl.), 378A (Abstract).
60.Rosso P. Maternal-fetal exchange during protein malnutrition in the rat. Placental transfer of glucose and a nonmetabolizable glucose analog. J Nutr. 1977; 107, 20006–20010.
61.Rosso P. Maternal-fetal exchange during protein malnutrition in the rat. Placental transfer of alpha-amino isobutyric acid. J Nutr. 1977; 107, 2002–2005.
62.Rosso P. Maternal malnutrition and placental transfer of alpha-aminoisobutyric acid in the rat. Science. 1975; 187, 648–650.
63.Varma DR, Ramakrishnan R. Effects of protein-calorie malnutrition on transplacental kinetics of aminoisobutyric acid in rats. Placenta. 1991; 12, 277–284.
64.Ahokas RA, Lahaye EB, Anderson GD, Lipshitz J. Effect of maternal dietary restriction on fetal growth and placental transfer of alpha-amino isobutyric acid in rats. J Nutr. 1981; 111, 2052–2058.
65.Belkacemi L, Jelks A, Chen CH, Ross MG, Desai M. Altered placental development in undernourished rats: role of maternal glucocorticoids. Reprod Biol Endocrinol. 2011; 9, 105.
66.Lesage J, Hahn D, Leonhardt M, et al. Maternal undernutrition during late gestation-induced intrauterine growth restriction in the rat is associated with impaired placental GLUT3 expression, but does not correlate with endogenous corticosterone levels. J Endocrinol. 2002; 174, 37–43.
67.Sferruzzi-Perri AN, Vaughan OR, Coan PM, et al. Placental-specific Igf2 deficiency alters developmental adaptations to undernutrition in mice. Endocrinology. 2011; 152, 3202–3212.
68.Coan PM, Vaughan OR, Sekita Y, et al. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J Physiol. 2010; 588, 527–538.
69.Coan PM, Vaughan OR, McCarthy J, et al. Dietary composition programmes placental phenotype in mice. J Physiol. 2011; 589, 3659–3670.
70.Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol. 2008; 32, 274–280.
71.Nitzan M, Orloff S, Schulman JD. Placental transfer of analogs of glucose and amino acids in experimental intrauterine growth retardation. Pediatr Res. 1979; 13, 100–103.
72.Glazier JD, Sibley CP, Carter AM. Effect of fetal growth restriction on system A amino acid transporter activity in the maternal facing plasma membrane of rat syncytiotrophoblast. Pediatr Res. 1996; 40, 325–329.
73.Reid GJ, Lane RH, Flozak AS, Simmons RA. Placental expression of glucose transporter proteins 1 and 3 in growth-restricted fetal rats. Am J Obstet Gynecol. 1999; 180, 1017–1023.
74.Jansson T, Persson E. Placental transfer of glucose and aminoacids in intrauterine growth retardation: studies with substrate analogs in the awake guinea pig. Pediatr Res. 1990; 28, 203–208.
75.Saintonge J, Rosso P. Placental blood flow and transfer of nutrient analogs in large, average, and small guinea pig littermates. Pediatr Res. 1981; 15, 152–156.
76.Coan PM, Angiolini E, Sandovici I, et al. Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J Physiol. 2008; 586, 4567–4576.
77.Barry JS, Rozance PJ, Anthony RV. An animal model of placental insufficiency-induced intrauterine growth restriction. Semin Perinatol. 2008; 32, 225–230.
78.Thureen PJ, Trembler KA, Meschia G, Makowski EL, Wilkening RB. Placental glucose transport in heat-induced fetal growth retardation. Am J Physiol. 1992; 263, R578–R585.
79.Ross JC, Fennessey PV, Wilkening RB, Battaglia FC, Meschia G. Placental transport and fetal utilization of leucine in a model of fetal growth retardation. Am J Physiol. 1996; 270, E491–E503.
80.Anderson AH, Fennessey PV, Meschia G, Wilkening RB, Battaglia FC. Placental transport of threonine and its utilization in the normal and growth-restricted fetus. Am J Physiol. 1997; 272, E892–E900.
81.de Vrijer B, Regnault TR, Wilkening RB, Meschia G, Battaglia FC. Placental uptake and transport of ACP, a neutral nonmetabolizable amino acid, in an ovine model of fetal growth restriction. Am J Physiol. 2004; 287, E1114–E1124.
82.Crowe C, Dandekar P, Fox M, et al. The effects of anaemia on heart, placenta and body weight, and blood pressure in fetal and neonatal rats. J Physiol. 1995; 488, 515–519.
83.Godfrey KM, Barker DJ. Maternal nutrition in relation to fetal and placental growth. Eur J Obstet Gynecol Reprod Biol. 1995; 61, 15–22.
84.Gambling L, Danzeisen R, Gair S, et al. Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. Biochem J. 2001; 356, 883–889.
85.Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358, 1991–2002.
86.Jansson T, Ekstrand Y, Björn C, Wennergren M, Powell TL. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes. 2002; 51, 2214–2219.
87.Kuruvilla AG, D'Souza SW, Glazier JD, et al. Altered activity of the system A amino acid transporter in microvillous membrane vesicles from placentas of macrosomic babies born to diabetic women. J Clin Invest. 1994; 94, 689–695.
88.Jansson T, Ekstrand Y, Wennergren M, Powell TL. Placental glucose transport in gestational diabetes. Am J Obstet Gynecol. 2001; 184, 111–116.
89.Jansson T, Wennergren M, Powell TL. Placental glucose transport and GLUT 1 expression in insulin dependent diabetes. Am J Obstet Gynecol. 1999; 180, 163–168.
90.Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999; 84, 695–701.
91.Persson A, Johansson M, Jansson T, Powell TL. Na+/K+-ATPase activity and expression in syncytiotrophoblast plasma membranes in pregnancies complicated by diabetes. Placenta. 2002; 23, 386–391.
92.Dicke JM, Henderson GI. Placental amino acid uptake in normal and complicated pregnancies. Am J Med Sci. 1988; 295, 223–227.
93.Bibee KP, Illsley NP, Moley KH. Asymmetric syncytial expression of GLUT9 splice variants in human term placenta and alterations in diabetic pregnancies. Reprod Sci. 2011; 18, 20–27.
94.Osmond DT, Nolan CJ, King RG, Brennecke SP, Gude NM. Effects of gestational diabetes on human placental glucose uptake, transfer, and utilisation. Diabetologia. 2000; 43, 576–582.
95.Osmond DT, King RG, Brennecke SP, Gude NM. Placental glucose transport and utilisation is altered at term in insulin-treated, gestational-diabetic patients. Diabetologia. 2001; 44, 1133–1139.
96.Desoye G, Gauster M, Wadsack C. Placental transport in pregnancy pathologies. Am J Clin Nutr. 2011; 94(Suppl 6), 1896S–1902S.
97.Gil-Sanchez A, Koletzko B, Larque E. Current understanding of placental fatty acid transport. Curr Opin Clin Nutr Metab Care. 2012; 15, 265–272.
98.Lindegaard MLS, Damm P, Mathiesen ER, Nielsen LB. Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res. 2006; 47, 2581–2588.
99.Scifres CM, Chen B, Nelson DM, Sadovsky Y. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab. 2011; 96, E1083–E1091.
100.Gauster M, Hiden U, van Poppel M, et al. Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes. 2011; 60, 2457–2464.
101.Wijendran V, Bendel RB, Couch SC, et al. Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids. 2000; 35, 927–931.
102.Higgins L, Greenwood SL, Wareing M, Sibley CP, Mills TA. Obesity and the placenta: a consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. Placenta. 2011; 32, 1–7.
103.Chu SY, Kim SY, Bish CL. Prepregnancy obesity prevalence in the United States, 2004–2005. Matern Child Health J. 2009; 13, 614–620.
104.Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001; 25, 1175–1182.
105.Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Publ Health. 2001; 91, 436–440.
106.Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004; 191, 964–968.
107.Farley DM, Choi J, Dudley DJ, et al. Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta. 2010; 31, 718–724.
108.Gaccioli F, Jansson T, Powell TL. Placental System A and System L amino acid transporter activity and expression in lean and overweight/obese Hispanic women. Reprod Sci. 2012; 19, 377A (Abstract).
109.Jansson N, Jones HN, Schumacher M, et al. Altered AMPK and mTOR signaling and up-regulation of placental System A amino acid transporter activity and SNAT2 protein expression in obese women giving birth to large babies. Reprod Sci. 2010; 17, 260A (Abstract).
110.Dube E, Gravel A, Martin C, et al. Modulation of fatty acid transport and metabolism by obesity in the human full-term placenta. Biol Reprod. 2012; May 2 [E-pub ahead of print].
111.Jawerbaum A, White V. Animal models in diabetes and pregnancy. Endocr Rev. 2010; 31, 680–701.
112.Palacin M, Lasuncion MA, Martin A, Herrera E. Decreased uterine blood flow in the diabetic pregnant rat does not modify the augmented glucose transfer to the fetus. Biol Neonate. 1985; 48, 197–203.
113.Eriksson U, Jansson L. Diabetes in pregnancy: decreased placental blood flow and disturbed fetal development in the rat. Pediatr Res. 1984; 18, 735–738.
114.Copeland AD Jr, Porterfield SP. Effects of streptozotocin-induced diabetes in pregnant rats on placental transport and tissue uptake of alpha-amino-isobutyric acid. Horm Metab Res. 1987; 19, 57–61.
115.Ogura K, Sakata M, Yamaguchi M, Kurachi H, Murata Y. High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo. J Endocrinol. 1999; 160, 443–452.
116.Devaskar S, Devaskar U, Schroeder R, et al. Expression of genes involved in placental glucose uptake and transport in the nonobese diabetic mouse pregnancy. Am J Obstet Gynecol. 1994; 171, 1316–1323.
117.Boileau P, Mrejen C, Girard J, Hauguel-de-Mouzon S. Overexpression of GLUT 3 placental glucose transporter in diabetic rats. J Clin Invest. 1995; 96, 309–317.
118.Herrera E, Palacin M, Martin A, Lasuncion M. Relationship between maternal and fetal fuels and placental glucose transfer in rats with maternal diabetes of varying severity. Diabetes. 1985; 34(Suppl 2), 42–46.
119.Thomas C, Lowy C. Placental transfer and uptake of 2-deoxyglucose in control and diabetic rats. Metabolism. 1992; 41, 1199–1203.
120.Honda M, Lowy C, Thomas CR. The effects of maternal diabetes on placental transfer of essential and non-essential fatty acids in the rat. Diabetes Res. 1990; 15, 47–51.
121.Shafrir E, Khassis S. Maternal-fetal fat transport versus new fat synthesis in the pregnant diabetic rat. Diabetologia. 1982; 22, 111–117.
122.Goldstein R, Levy E, Shafrir E. Increased maternal-fetal transport of fat in diabetes assessed by polyunsaturated fatty acid content in fetal lipids. Biol Neonate. 1985; 47, 343–349.
123.Li M, Sloboda DM, Vickers MH. Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Exp Diabetes Res. 2011; 2011, 592408. Epub 28 September 2011.
124.Armitage JA, Khan IY, Taylor PD, Nathanielsz PW, Poston L. Developmental programming of metabolic syndrome by maternal nutritional imbalance; how strong is the evidence from expermental models in animals. J Physiol. 2004; 561, 355–377.
125.Wallace JM, Bourke DA, Aitken RP, Milne JS, Hay WW Jr. Placental glucose transport in growth-restricted pregnancies induced by adolescent sheep. J Physiol. 2003; 547, 85–94.
126.Frias AE, Morgan TK, Evans AE, et al. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology. 2011; 152, 2456–2464.
127.Jones HN, Woollett LP, Barbour N, et al. High fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/Bl6 mice. FASEB J. 2009; 23, 271–278.
128.Rebholz SL, Burke KT, Yang Q, Tso P, Woollett LA. Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab. 2011; 301, E416–E425.
129.Jones HN, Powell TL, Jansson T. Regulation of placental nutrient transport – a review. Placenta. 2007; 28, 763–774.
130.Lager S, Powell TL. Regulation of transport across the placenta. J Pregnancy. 2012 (In Press).
131.Longo VD, Fontana L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci. 2010; 31, 89–98.
132.Holmes R, Montemagno R, Jones J, et al. Fetal and maternal plasma insulin-like growth factors in pregnancies with appropriate or retarded fetal growth. Early Hum Dev. 1997; 49, 7–17.
133.Yildiz L, Avci B, Ingec M. Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. Clin Chem Lab Med. 2002; 40, 1114–1117.
134.Potau N, Riudor E, Ballabriga A. Insulin receptors in human placenta in relation to fetal weight and gestational age. Pediatr Res. 1981; 15, 798–802.
135.Laviola L, Perrini S, Belsanti G, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 2005; 146, 1498–1505.
136.Lea RG, Howe D, Hannah LT, et al. Placental leptin in normal diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod. 2000; 6, 763–769.
137.Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular and inflammatory pathways. J Clin Endocrinol Metab. 2002; 87, 4231–4237.
138.Jansson N, Nilsfelt A, Gellerstedt M, et al. Maternal hormones linking maternal bodymass index and dietary intake to birth weight. Am J Clin Nutr. 2008; 87, 1743–1749.
139.Lauszus FF, Klebe JG, Flyvbjerg A. Macrosomia associated with maternal serum insulin-like growth factor-I and -II in diabetic pregnancy. Obstet Gynecol. 2001; 97, 734–741.
140.Karl PI. Insulin-like growth factor-1 stimulates amino acid uptake by the cultured human placental trophoblast. J Cell Physiol. 1995; 165, 83–88.
141.Karl PI, Alpy KL, Fischer SE. Amino acid transport by the cultured human placental trophoblast: effect of insulin on AIB transport. Am J Physiol. 1992; 262, C834–C839.
142.Jones HN, Jansson T, Powell TL. IL-6 stimulates System A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell. 2009; 297, C1228–C1235.
143.Jones HN, Jansson T, Powell TL. Full length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino acid transport in human primary trophoblast cells. Diabetes. 2010; 59, 1161–1170.
144.Rosario FJ, Schumacher MA, Jiang J, et al. Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth. J Physiol. 2012; 590, 1495–1509.
145.Sferruzzi-Perri AN, Owens JA, Standen P, et al. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrition partitioning near term. Am J Physiol Endocrinol Metab. 2006; 292, E668–E676.
146.Audette MC, Challis JR, Jones RL, Sibley CP, Matthews SG. Antenatal dexamethasone treatment in midgestation reduces system A-mediated transport in the late-gestation murine placenta. Endocrinology. 2011; 152, 3561–3570.
147.Desoye G, Hartmann M, Blaschitz A, et al. Insulin receptors in syncytiotrophoblast and fetal endothelium of human placenta. Immunohistochemical evidence for developmental changes in distribution pattern. Histochemistry. 1994; 101, 277–285.
148.Ebenbichler CF, Kasser S, Laimer M, et al. Polar expression and phosphorylation of human leptin receptor isoforms in paired syncytial, microvillous and basal membranes from human term placenta. Placenta. 2002; 23, 516–521.
149.Fang J, Furesz TC, Lurent RS, Smith CH, Fant M. Spatial polarization of insulin-like growth factor receptors on the human syncytiotrophoblast. Pediatr Res. 1997; 41, 258–265.
150.Jansson T, Aye ILMH, Goberdhan DCI. The emerging role of mTORC1 signalling in placental nutrient-sensing. Placenta. 2012 June 9. [Epub ahead of print].
151.Yung HW, Calabrese S, Hynx D, et al. Evidence of translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol. 2008; 173, 311–314.
152.Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011; 12, 21–35.
153.Roos S, Kanai Y, Prasad PD, Powell TL, Jansson T. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am J Physiol Cell. 2009; 296, C142–C150.
154.Roos S, Jansson N, Palmberg I, et al. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted foetal growth. J Physiol. 2007; 582, 449–459.
155.Gaccioli F, Jansson T, Powell TL. Activation of placental mammalian target of rapamycin signaling in obese women. Placenta. 2011; 32, A134 Abstract.
156.Arroyo JA, Brown LD, Galan HL. Placental mammalian target of rapamycin and related signaling pathways in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol. 2009; 201, 616e611–616e617.
157.Coan PM, Burton GJ, Ferguson-Smith AC. Imprinted genes in the placenta – a review. Placenta. 2005; 26(Suppl. A), S10–S20.
158.Coan PM, Fowden AL, Constancia M, et al. Disproportional effects of Igf2 knockout on placental morphology and diffusional exchange characteristics in the mouse. J Physiol. 2008; 586, 5023–5032.
159.Smerieri A, Petraroli M, Ziveri MA, et al. Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: pilot study. PLoS One. 2011; 6, e29562.
160.Christou H, Connors JM, Ziotopoulou M, et al. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab. 2001; 86, 935–938.
161.Strid H, Care AD, Jansson T, Powell TL. PTHrp midmolecule stimulates Ca2+ ATPase in human syncytiotrophoblast basal membrane. J Endocrinol. 2002; 175, 517–524.
162.Godfrey KM, Matthews N, Glazier J, et al. Neutral amino acid uptake by microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy. J Clin Endocrinol Metab. 1998; 83, 3320–3326.